The FDA approved a monthly maintenance dosing of intravenous lecanemab (Leqembi) for early Alzheimer's disease, said ...
Anavex’s newest patent will be expected to remain in force at least until July 2039, not including any patent term extensions. It will expand and supplement the current ANAVEX®2-73 (blarcamesine) ...
South San Francisco, CA, January 30, 2025 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has awarded nearly ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company with a market capitalization of $3.06 billion, focuses on developing and commercializing innovative medicines to address unmet ...
Dogs in UK Are First to Be Trained to Sniff Out Bowel Cancer–After Nailing Parkinson’s and COVID
Medical Detection Dogs are the first in the UK to be trained to sniff out bowel cancer tumors by smelling urine in ...
Web accessibility is about making web content available to users with disabilities. Development teams can use the success ...
Anavex Life Sciences (AVXL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram ...
Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...
Cocker Spaniels Mango, Callie and Dotty, Labradors Hetty, Rosie and Jodie, and Flat-coated Retriever Willow are showing real ...
First Coast News is teaming up with Who We Play For for a community heart screening event Feb. 11, 2025 in Jacksonville.
It’s a lack of movement It’s a lack of movement “Parkinson’s is a syndrome that is diagnosed based on the presence of a set of physical exam findings, which are tremor, rigidity, akinesis, or a lack ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback